Alkem Laboratories ke shares ₹930 crore mein block deal se beche gaye; promoters ne stake mutual funds aur FIIs ko becha
मुख्य बातें
- •Promoter-linked entities ne Alkem Laboratories ke 17.88 lakh shares ₹5,200 per share ke hisaab se beche, jiska total transaction value ₹930 crore hai.
- •Jayanti Sinha ne 12.38 lakh shares beche, jabki Samprada & Nanhamati Singh Family Trust ne 5.5 lakh shares offloaded kiye.
- •ICICI Prudential Mutual Fund (9.04 lakh shares) aur HDFC Mutual Fund (5.1 lakh shares) sabse bade buyers mein shaamil the.
- •Deal ke pehle strong share price performance domestic formulations growth, margin improvement, aur US business recovery se driven thi.
- •Major domestic mutual funds ke involvement se quality healthcare stocks per sustained institutional interest ka pata chalta hai.
- •Promoter shareholding transaction ke baad kam hogi, jisse future ownership aur capital structure changes par investor focus badhega.
- •Alkem Laboratories ek leading Indian pharmaceutical company hai, jiska diversified presence acute therapies, chronic care, aur international markets mein hai.
Mangalvar ko Alkem Laboratories Ltd ke shares mein ek bada block deal dekha gaya, jismein promoters se judi entities ne ₹5,200 per share ke hisaab se total 17.88 lakh shares beche, jiska transaction value lagbhag ₹930 crore hai. National Stock Exchange (NSE) ke data ke mutaabik, is block deal mein do sellers se ek diversified group of institutional buyers ko ownership transfer hui, jismein domestic mutual funds aur Foreign Institutional Investors (FIIs) shamil the.